|
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons Clinical research trials and A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons. A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons clinical trial. Participants oftentimes recieve the most expert healthcare available for their A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons  A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons
For Condition: Herpes Genitalis,HIV Infections
Status: Recruiting
Sponsor(s): Sponsor Name Pending ,
Synopsis: This clinical research study will be an international trial evaluating the safety and effectiveness of a marketed drug compared to placebo (like a sugar pill) for the suppression of repeated genital herpes infections in HIV-infected subjects with CD4+ count <100 cells/mm3.
Details:
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria (a subject must meet the following criteria in order to be considered eligible for this study): - CD4+ lymphocyte count <100cells/mm3 at the screening visit. - Documented history of HIV infections. - Must have received stable, combination anti HIV drugs for at least 4 months immediately prior to participation, and per the investigator, are unlikely to require change in anti HIV drugs during the six-month study. - Laboratory confirmation of genital herpes (a positive Herpes Simplex Virus-2 antibody test). - 3 or more outbreaks of genital herpes in the previous 12 months if not on genital herpes medicines currently. - 3 or more outbreaks of genital herpes per year in the period prior to beginning of treatment for chronic genital herpes. Exclusion Criteria (a subject cannot meet the following criteria in order to be considered eligible for this study): - Kidney diseases. - Liver diseases. - Known allergic reactions to VALTREX (valaciclovir), ZOVIRAX (acyclovir), Famvir (famciclovir), or Cytovene (ganciclovir). - Vomiting syndrome. - Must be willing to discontinue taking current genital herpes medicines 1 week prior to participation. - Active AIDS-indicator conditions, as defined by CDC Category C. - Other protocol inclusion and exclusion criteria to be evaluated by the research physician.
Total Enrollment:
Location and Contact Information:
Study Site *Not yet recruiting*
Seattle, Washington, 98122
United States
Not yet recruiting Study Coordinator 206-386-2820
Study Site *Recruiting*
Ft. Myers, Florida, 33901
United States
Recruiting Study Coordinator 239-278-4272
Study Site *Recruiting*
Altamonte Springs, Florida, 32701
United States
Recruiting Study Coordinator 407-647-3960
Study Site *Recruiting*
Dallas, Texas, 75246
United States
Recruiting Study Coordinator 214-828-4702
Study Site *Not yet recruiting*
St. Louis, Missouri, 63108
United States
Not yet recruiting Study Coordinator 314-454-1900
Study Site *Recruiting*
Beverly Hills, California, 90211
United States
Recruiting Study Coordinator 310-652-8729
Study Site *Not yet recruiting*
Ft. Worth, Texas, 76104
United States
Not yet recruiting Study Coordinator 817-810-9810
Study Site *Not yet recruiting*
Chicago, Illinois, 60657
United States
Not yet recruiting Study Coordinator 773-296-2400
Study Site *Recruiting*
Boston, Massachusetts, 02115
United States
Recruiting Study Coordinator 617-927-6056
Study Site *Recruiting*
Voorhees, New Jersey, 08043
United States
Recruiting Study Coordinator 856-566-3190
Study Site *Not yet recruiting*
Denver, Colorado, 80104
United States
Not yet recruiting Study Coordinator 303-436-7204
Additional Information:
Study ID Numbers: HS2100181;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00079911
Other Herpes Genitalis Studies:
1. A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
2. A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons
3. Treating Genital Herpes to Decrease Risk of HIV Acquisition
Related Studies:
Other Herpes Genitalis Clinical Trials
Other California Clinical Trials
Other Beverly Hills Clinical Trials
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection in HIV-Infected Persons
|
|
|
|
|
|
|
|
